Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot
LONDON, England — Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. British researchers first began testing the vaccine in April in about 1,000 people, half of whom got the experimental vaccine. Such early trials are usually designed only to evaluate safety, but in this case, experts were also looking to see what kind of immune response was provoked. In research published Monday in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. »We are seeing good immune response in almost everybody, » said Dr. Adrian Hill, director of the Jenner Institute at Oxford University. « What this vaccine does particularly well is trigger both arms of the immune system, » he said. Hill said that neutralizing antibodies are produced – molecules which are key to blocking infection. In addition, the vaccine also causes a reaction in the body’s T-cells which help to fight off the coronavirus. He said that larger trials evaluating the vaccine’s effectiveness, involving about 10,000 people in the U. K., as well as participants in South Africa and Brazil, are still underway.
